Skip to main content
. 2014 Apr 30;93(9):1515–1522. doi: 10.1007/s00277-014-2090-4

Fig. 3.

Fig. 3

Validation analysis for MDS-specific point mutations. Validation analysis of the MDS-specific point mutations. Sanger sequence conducted to validate point mutations identified by whole-genome sequencing. For the HECW2 mutation, the nucleotide substitution was described as opposite strand (G > A to C > T)